PE20051163A1 - Formas de dosificacion oral de acido n-(2-(2-ftalimido-etoxi)-acetil)-l-alanil-d-glutamico (lk 423) - Google Patents
Formas de dosificacion oral de acido n-(2-(2-ftalimido-etoxi)-acetil)-l-alanil-d-glutamico (lk 423)Info
- Publication number
- PE20051163A1 PE20051163A1 PE2005000349A PE2005000349A PE20051163A1 PE 20051163 A1 PE20051163 A1 PE 20051163A1 PE 2005000349 A PE2005000349 A PE 2005000349A PE 2005000349 A PE2005000349 A PE 2005000349A PE 20051163 A1 PE20051163 A1 PE 20051163A1
- Authority
- PE
- Peru
- Prior art keywords
- acid
- glutamico
- alanil
- etoxy
- phthalimido
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
REFERIDA A UNA FORMA DE DOSIFICACION COMO MICROCAPSULA QUE COMPRENDE UN NUCLEO DE (A) UNA SUSTANCIA ACTIVA DE ACIDO N-(2-(2-FTALIMIDO-ETOXI)-ACETIL)-L-ALANIL-D-GLUTAMICO Y UN POLISACARIDO COMO PECTINA O ALGINATO Y UN DERRAPANTE COMO UN ESTEARATO DE CALCIO O MAGNESIO, ENTRE OTROS; (B) UN RECUBRIMIENTO INTERNO TAL COMO COPOLIMERO DE ACIDO METACRILICO, FTALATO DE HIDROXI-PROPIL-METIL-CELULOSA, FTALATO DE ACETATO DE CELULOSA, ENTRE OTROS; (C) UN RECUBRIMIENTO EXTERNO TAL COMO EL POLIMERO EUDRAGIT L-55, TALCO Y CITRATO DE TRIETILO. DICHA COMPOSICION ACTIVA AL ILEO, CECO Y COLON, Y SE ADMINISTRA DE 10 A 1000 mg EN UNA O MAS DOSIS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SI200400094 | 2004-03-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20051163A1 true PE20051163A1 (es) | 2006-02-21 |
Family
ID=34964906
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2005000349A PE20051163A1 (es) | 2004-03-26 | 2005-03-28 | Formas de dosificacion oral de acido n-(2-(2-ftalimido-etoxi)-acetil)-l-alanil-d-glutamico (lk 423) |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20100183714A1 (es) |
| EP (1) | EP1734933B1 (es) |
| JP (1) | JP2007530492A (es) |
| CN (1) | CN1956707B (es) |
| AR (1) | AR048342A1 (es) |
| AT (1) | ATE468846T1 (es) |
| AU (1) | AU2005226927B2 (es) |
| BR (1) | BRPI0509271A (es) |
| CA (1) | CA2559685A1 (es) |
| DE (1) | DE602005021475D1 (es) |
| MY (1) | MY145329A (es) |
| PE (1) | PE20051163A1 (es) |
| RU (1) | RU2375047C2 (es) |
| TW (1) | TW200600121A (es) |
| WO (1) | WO2005092295A1 (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2081557A1 (en) * | 2006-11-17 | 2009-07-29 | DA Volterra | Colonic delivery using zn/pectin beads with a eudragit coating. |
| US8273376B2 (en) | 2006-11-17 | 2012-09-25 | Da Volterra | Colonic delivery of metallo-dependent enzymes |
| US20100239682A1 (en) * | 2007-09-17 | 2010-09-23 | Antoine Andremont | Colonic delivery of antimicrobial agents |
| SMT201700346T1 (it) | 2008-11-13 | 2017-09-07 | Nogra Pharma Ltd | Composizioni antisenso e metodi per la loro preparazione e loro uso |
| EP3302703B1 (en) * | 2015-06-01 | 2021-08-25 | Xeno Biosciences Inc. | Compositions for use in modulating the gut microbiota and managing weight |
| CN109562158A (zh) * | 2016-06-23 | 2019-04-02 | 纽特莱特公司 | 在动物中促进生长和提高饲料转化率的方法 |
| CN110520534A (zh) * | 2016-11-09 | 2019-11-29 | 恩根尼公司 | 程序性死亡配体1的肠表达 |
| BR112019012062A2 (pt) | 2016-12-14 | 2019-11-12 | Progenity Inc | tratamento de uma doença do trato gastrointestinal com um inibidor de jak e dispositivos |
| CN110430801B (zh) * | 2016-12-14 | 2024-04-30 | 比奥拉治疗股份有限公司 | 使用tnf抑制剂治疗胃肠道疾病 |
| BR112019012071A2 (pt) * | 2016-12-14 | 2019-11-12 | Progenity Inc | tratamento de uma doença do trato gastrointestinal com um inibidor de integrina |
| CN108968074B (zh) * | 2018-06-06 | 2021-09-28 | 福建省农业科学院农业工程技术研究所 | 一种结肠靶向递送的银耳糖醛酸多糖-芙蓉李花青素复合物及其制备方法 |
| KR102104507B1 (ko) * | 2019-08-23 | 2020-04-24 | 브릿지바이오테라퓨틱스(주) | 팔미토일-l-프롤릴-l-프롤릴-글리실-l-타이로신 나트륨을 포함하는 약제학적 제제 및 이의 제조방법 |
| EP4126040B1 (en) | 2020-03-26 | 2025-02-19 | Nutrivert Inc. | Lipophilic enantiomers of desacetylglucosamine muramyl dipeptide with anti-inflammatory and growth promoting activity |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0527942B1 (en) * | 1990-05-04 | 1999-10-06 | Perio Products Limited | Colonic drug delivery system |
| JP2773959B2 (ja) * | 1990-07-10 | 1998-07-09 | 信越化学工業株式会社 | 大腸内放出性固形製剤 |
| SI9011830B (sl) * | 1990-09-27 | 1999-12-31 | Univerza V Ljubljani, Fakulteta Za Farmacijo | Novi N-acildipeptidi, postopki za njihovo pripravo in farmacevtski pripravki, ki jih vsebujejo |
| DE19732903A1 (de) * | 1997-07-30 | 1999-02-04 | Falk Pharma Gmbh | Pellet-Formulierung zur Behandlung des Intestinaltraktes |
| UA73092C2 (uk) * | 1998-07-17 | 2005-06-15 | Брістол-Майерс Сквібб Компані | Таблетка з ентеросолюбільним покриттям і спосіб її приготування |
| US6627223B2 (en) * | 2000-02-11 | 2003-09-30 | Eurand Pharmaceuticals Ltd. | Timed pulsatile drug delivery systems |
-
2005
- 2005-03-24 WO PCT/EP2005/003175 patent/WO2005092295A1/en not_active Ceased
- 2005-03-24 RU RU2006137660/15A patent/RU2375047C2/ru not_active IP Right Cessation
- 2005-03-24 EP EP05733297A patent/EP1734933B1/en not_active Expired - Lifetime
- 2005-03-24 CN CN2005800168849A patent/CN1956707B/zh not_active Expired - Fee Related
- 2005-03-24 MY MYPI20051274A patent/MY145329A/en unknown
- 2005-03-24 US US10/599,289 patent/US20100183714A1/en not_active Abandoned
- 2005-03-24 JP JP2007504366A patent/JP2007530492A/ja active Pending
- 2005-03-24 AT AT05733297T patent/ATE468846T1/de active
- 2005-03-24 DE DE602005021475T patent/DE602005021475D1/de not_active Expired - Fee Related
- 2005-03-24 AU AU2005226927A patent/AU2005226927B2/en not_active Ceased
- 2005-03-24 BR BRPI0509271-0A patent/BRPI0509271A/pt not_active IP Right Cessation
- 2005-03-24 CA CA002559685A patent/CA2559685A1/en not_active Abandoned
- 2005-03-28 AR ARP050101197A patent/AR048342A1/es unknown
- 2005-03-28 PE PE2005000349A patent/PE20051163A1/es not_active Application Discontinuation
- 2005-03-28 TW TW094109593A patent/TW200600121A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2006137660A (ru) | 2008-05-10 |
| AU2005226927A1 (en) | 2005-10-06 |
| AU2005226927B2 (en) | 2010-09-23 |
| AR048342A1 (es) | 2006-04-19 |
| CA2559685A1 (en) | 2005-10-06 |
| EP1734933B1 (en) | 2010-05-26 |
| RU2375047C2 (ru) | 2009-12-10 |
| EP1734933A1 (en) | 2006-12-27 |
| US20100183714A1 (en) | 2010-07-22 |
| WO2005092295A1 (en) | 2005-10-06 |
| MY145329A (en) | 2012-01-31 |
| TW200600121A (en) | 2006-01-01 |
| ATE468846T1 (de) | 2010-06-15 |
| JP2007530492A (ja) | 2007-11-01 |
| CN1956707B (zh) | 2010-12-29 |
| CN1956707A (zh) | 2007-05-02 |
| BRPI0509271A (pt) | 2007-09-04 |
| DE602005021475D1 (de) | 2010-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1980647B (zh) | 包含组蛋白脱乙酰酶抑制剂的制剂 | |
| PE20051163A1 (es) | Formas de dosificacion oral de acido n-(2-(2-ftalimido-etoxi)-acetil)-l-alanil-d-glutamico (lk 423) | |
| KR101834033B1 (ko) | 주의력 결핍 장애 치료용 고체 경구 제약 조성물 | |
| JP6037840B2 (ja) | 口腔内崩壊錠 | |
| KR870009717A (ko) | 신규 경구용 약제 | |
| JP2009545560A5 (es) | ||
| JP2005532372A5 (es) | ||
| DE60032749D1 (de) | Stabilisierte pharmazeutische zusammensetzung enthaltend einen nichtsteroiden entzündungshemmenden wirkstoff und prostaglandin | |
| JPWO2008081891A1 (ja) | 口腔内崩壊性固形製剤 | |
| US10004691B2 (en) | Orally disintegrable tablet | |
| WO2004064810A1 (ja) | 口腔内速崩性錠剤 | |
| BR112018001859B1 (pt) | Comprimido, e, método para produzir um comprimido | |
| CN1046459A (zh) | 剂量形式的美贝维林 | |
| KR100583065B1 (ko) | 프로그램화 및 펄스화 방출식 다립형 의약 제형 및 그의 제조 방법 | |
| CO5540278A2 (es) | Formulacion farmaceutica de sabor enmascarado y procedimiento para su preparacion | |
| JP4730985B2 (ja) | 安定化された医薬製剤 | |
| ES2487634T3 (es) | Formulaciones de 4-metilpirazol | |
| JP2017222645A (ja) | 腸溶性被覆顆粒の耐酸性が改善された圧縮成形錠剤 | |
| JP5973347B2 (ja) | 口腔内崩壊錠 | |
| BRPI0620788A2 (pt) | preparação sólida | |
| RU2008151945A (ru) | Лекарственные формы с пульсирующим высвобождением и фармацевтические композиции фенилэфрина | |
| JP2008515980A5 (es) | ||
| WO2021244481A1 (en) | Compositions and methods for treating a sars-cov-2 infection | |
| DE602006009556D1 (de) | Chinolin-derivate zur behandlung von mglur5-rezeptor-vermittelten erkrankungen | |
| JP2012144564A (ja) | 医薬組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |